Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0000950170-25-110774

Chief Legal Officer sold 676 shares at $26.59 ($17,975)

From the SEC's structured data for this filing

Trades in this filing

Wilson Mark Andrew · Chief Legal Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-08-19 Sale : show line 1 in the form −676 $26.59 $17,975 20,312 D
Open-market sales · 676 sh · avg $26.59 · $17,975

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-08-19 Grant or award : show line 2 in the form Stock Option +21,666 21,666 D
Loading xslF345X05/ownership.xml…